MCPyV and Oxidative Stress: Focus on Mechanism of Action Associated with Merkel Cell Carcinoma
-
Hana lotfi
,
Alireza Esfandiari
,
Masoomeh Zarezadeh
,
Zahra Talebi
,
Alireza Etrati Kooshali
,
Nasim Sheydaei
,
Mina Naderisemiromi
Abstract
Merkel cell carcinoma (MCC) is a life-threatening, aggressive cancer. MCV genome integration into epidermal keratinocytes or dermal fibroblasts leads to polyomavirus-associated MCC (MCCP). Many cancer types show an increased amount of reactive oxygen species (ROS) in the growing and metastatic phases. An increase in the oxidative stress pathway results in an elevated amount of ROS. It is supposed that MCV uses the same mechanisms for inducing cancer. It can be considered that viral MCCs could be the result of oxidative stress pathways in the MCC-causing viral agent, the Merkel cell polyomavirus (MCPyV). The objective of this study was to examine the role of oxidative stress in cancers associated with Merkel cell polyomavirus (MCV). The search strategy was performed in PubMed, NCBI, Google Scholar, EMBASE, and Medline on cancer, oxidative stress, and gene manipulation up to 10 June 2022 by searching the following keywords: MCV, oxidative stress, cancer, and MCC. The cells’ uncontrolled increase in ROS amounts results in difficulties including changes in genome structure and instability. Some of these changes account for unwanted replication and inflammation in damaged cells. This investigation of the oxidative stress pathway and its role in MCC highlights new approaches for cancer therapy methods. These free radicals have been proposed to significantly contribute to DNA damage, and reactive oxygen species (ROS) are considered key mediators in the development of Merkel cell carcinoma.
References
[1] Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778-89. https://doi.org/10.1002/ijc.33588
[2] Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108. https://doi.org/10.3322/canjclin.55.2.74
[3] zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392(1):1-10. https://doi.org/10.1016/j.virol.2009.06.001
[4] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2011;100B:1-636.
[5] Zuckerman AJ. IARC monographs on the evaluation of carcinogenic risks to humans. J Clin Pathol. 1995;48(7):691. https://doi.org/10.1136/jcp.48.7.691-a
[6] Qian W, Wiman KG. Polyoma virus middle T and small t antigens cooperate to antagonize p53-induced cell cycle arrest and apoptosis. Cell Growth Differ. 2000;11(1):31-9.
[7] Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107-10. https://doi.org/10.1001/archderm.1972.01620040075020
[8] Urso C. A tumour, a cell, a misunderstanding: trabecular (Merkel cell) carcinoma of the skin. J Clin Pathol. 1991;44(9):781. https://doi.org/10.1136/jcp.44.9.781
[9] Spurgeon ME, Lambert PF. Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology. 2013;435(1):118-30. https://doi.org/10.1016/j.virol.2012.09.029
[10] Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077. https://doi.org/10.1038/nrdp.2017.77
[11] Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 5th ed. Oxford: Oxford University Press; 2015. https://doi.org/10.1093/acprof:oso/9780198717478.001.0001
[12] Wongworawat YC, Filippova M, Williams VM, Filippov V, Duerksen-Hughes PJ. Chronic oxidative stress increases the integration frequency of foreign DNA and human papillomavirus 16 in human keratinocytes. Am J Cancer Res. 2016;6(4):764-80.
[13] Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994;344(8924):721-4. https://doi.org/10.1016/S0140-6736(94)92211-X
[14] Battisti V, Maders LD, Bagatini MD, Reetz LG, Chiesa J, Battisti IE, et al. Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis. Biomed Pharmacother. 2011;65(7):516-24. https://doi.org/10.1016/j.biopha.2011.06.003
[15] Liu W, Krump NA, Buck CB, You J. Merkel cell polyomavirus infection and detection. J Vis Exp. 2019;(144):e58950. https://doi.org/10.3791/58950
[16] Liu W, Yang R, Payne AS, Schowalter RM, Spurgeon ME, Lambert PF, et al. Identifying the target cells and mechanisms of Merkel cell polyomavirus infection. Cell Host Microbe. 2016;19(6):775-87. https://doi.org/10.1016/j.chom.2016.04.024
[17] Chang Y, Moore PS. Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol. 2012;7:123-44. https://doi.org/10.1146/annurev-pathol-011110-130227
[18] Calzavara-Pinton P, Monari P, Manganoni AM, Ungari M, Rossi M, Gualdi G, et al. Merkel cell carcinoma arising in immunosuppressed patients treated with high-dose ultraviolet A1 (320-400 nm) phototherapy: a report of two cases. Photodermatol Photoimmunol Photomed. 2010;26(5):263-5. https://doi.org/10.1111/j.1600-0781.2010.00529.x
[19] Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077. https://doi.org/10.1038/nrdp.2017.77
[20] Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107-10. https://doi.org/10.1001/archderm.1972.01620040075020
[21] Colunga A, Pulliam T, Nghiem P. Merkel cell carcinoma in the age of immunotherapy: facts and hopes. Clin Cancer Res. 2017;24(9):2035-43. https://doi.org/10.1158/1078-0432.CCR-17-0439
[22] Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096-100. https://doi.org/10.1126/science.1152586
[23] Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009;5(9):e1000578. https://doi.org/10.1371/journal.ppat.1000578
[24] Schowalter RM, Pastrana DV, Buck CB. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog. 2011;7(7):e1002161. https://doi.org/10.1371/journal.ppat.1002161
[25] Schowalter RM, Reinhold WC, Buck CB. Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One. 2012;7(7):e42181. https://doi.org/10.1371/journal.pone.0042181
[26] Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe. 2010;7(6):509-15. https://doi.org/10.1016/j.chom.2010.05.006
[27] Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, et al. Human Merkel cell polyomavirus infection II. Int J Cancer. 2009;125(6):1250-6. https://doi.org/10.1002/ijc.24509
[28] Czech-Sioli M, Günther T, Therre M, Spohn M, Indenbirken D, Theiss J, et al. High-resolution analysis of Merkel cell polyomavirus. PLoS Pathog. 2020;16(6):e1008562. https://doi.org/10.1371/journal.ppat.1008562
[29] Martel-Jantin C, Filippone C, Cassar O, Peter M, Tomasic G, Vielh P, et al. Genetic variability and integration of Merkel cell polyomavirus. Virology. 2012;426(2):134-42. https://doi.org/10.1016/j.virol.2012.01.018
[30] Starrett GJ, Thakuria M, Chen T, Marcelus C, Cheng J, Nomburg J, et al. Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med. 2020;12(1):30. https://doi.org/10.1186/s13073-020-00727-4
[31] Borchert S, Czech-Sioli M, Neumann F, Schmidt C, Wimmer P, Dobner T, et al. High-affinity Rb binding and transformation by Merkel cell polyomavirus large T antigens. J Virol. 2014;88(6):3144-60. https://doi.org/10.1128/JVI.02916-13
[32] Houben R, Adam C, Baeurle A, Hesbacher S, Grimm J, Angermeyer S, et al. Retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen. Int J Cancer. 2012;130(4):847-56. https://doi.org/10.1002/ijc.26076
[33] Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, et al. Pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol. 2009;218(1):48-56. https://doi.org/10.1002/path.2532
[34] Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. T antigen mutations are a human tumor-specific signature. Proc Natl Acad Sci USA. 2008;105(42):16272-7. https://doi.org/10.1073/pnas.0806526105
[35] Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, et al. Viral T antigens required for Merkel cell carcinoma cells. J Virol. 2010;84(14):7064-72. https://doi.org/10.1128/JVI.02400-09
[36] Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. Small T antigen targeting 4E-BP1. J Clin Invest. 2011;121(9):3623-34. https://doi.org/10.1172/JCI46323
[37] Verhaegen ME, Mangelberger D, Harms PW, Vozheiko TD, Weick JW, Wilbert DM, et al. Small T antigen is oncogenic in transgenic mice. J Invest Dermatol. 2015;135(5):1415-24. https://doi.org/10.1038/jid.2014.446
[38] Grundhoff A, Fischer N. Merkel cell polyomavirus. Curr Opin Virol. 2015;14:129-37. https://doi.org/10.1016/j.coviro.2015.08.010
[39] Liu W, Krump NA, You J. Merkel cell polyomavirus infection and carcinoma. Curr Opin Virol. 2016;20:20-7. https://doi.org/10.1016/j.coviro.2016.07.011
[40] Liu W, You J. Molecular mechanisms of transformation and replication. Annu Rev Virol. 2020;7:289-307. https://doi.org/10.1146/annurev-virology-011720-121757
[41] Spurgeon ME, Lambert PF. Merkel cell polyomavirus. Virology. 2013;435(1):118-30. https://doi.org/10.1016/j.virol.2012.09.029
[42] Wendzicki JA, Moore PS, Chang Y. Large T and small T antigens. Curr Opin Virol. 2015;11:38-43. https://doi.org/10.1016/j.coviro.2015.01.009
[43] Terheyden P, Becker JC. New developments in metastatic Merkel cell carcinoma. Curr Opin Oncol. 2017;29(3):221-6. https://doi.org/10.1097/CCO.0000000000000363
[44] Tang CK, Toker C. Trabecular carcinoma: ultrastructural study. Cancer. 1978;42(5):2311-21. https://doi.org/10.1002/1097-0142(197811)42:5<2311::AID-CNCR2820420531>3.0.CO;2-L
[45] Chen T, Hudnall SD, Buck CB, Feng H, Moore PS, Chang Y. Serological evidence of primary infections in childhood. J Clin Virol. 2011;50(2):125-9. https://doi.org/10.1016/j.jcv.2010.10.015
[46] Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009;5(3):e1000363. https://doi.org/10.1371/journal.ppat.1000363
[47] Tolstov YL, Knauer A, Chen JG, Kensler TW, Chang Y, Moore PS. Asymptomatic primary infection among adults. Emerg Infect Dis. 2011;17(8):1371-80. https://doi.org/10.3201/eid1708.110079
[48] Touzé A, Le Bidre E, Laude H, Fleury MJ, Cazal R, Arnoult D, et al. Antibodies and clinical outcome. J Clin Oncol. 2011;29(12):1612-9. https://doi.org/10.1200/JCO.2010.31.1704
[49] Pastrana DV, Wieland U, Silling S, Buck CB, Pfister H. Viral load and antibody titer correlation. Med Microbiol Immunol. 2012;201(1):17-23. https://doi.org/10.1007/s00430-011-0200-7
[50] Viscidi RP, Rollison DE, Sondak VK, Silver B, Messina JL, Giuliano AR, et al. Age-specific seroprevalence. Clin Vaccine Immunol. 2011;18(10):1737-43. https://doi.org/10.1128/CVI.05175-11
[51] Wieland U, Mauch C, Kreuter A, Krieg T, Pfister H. Merkel cell polyomavirus DNA in persons without carcinoma. Emerg Infect Dis. 2009;15(9):1496-8. https://doi.org/10.3201/eid1509.081575
[52] Abedi Kiasari B, Vallely PJ, Klapper PE. Merkel cell polyomavirus DNA in respiratory disease. J Med Virol. 2011;83(12):2220-4. https://doi.org/10.1002/jmv.22222
[53] Bialasiewicz S, Lambert SB, Whiley DM, Nissen MD, Sloots TP. Merkel cell polyomavirus DNA in respiratory specimens. Emerg Infect Dis. 2009;15(3):492-4. https://doi.org/10.3201/eid1503.081067
[54] Goh S, Lindau C, Tiveljung-Lindell A, Allander T. Merkel cell polyomavirus in respiratory secretions. Emerg Infect Dis. 2009;15(3):489-91. https://doi.org/10.3201/eid1503.081206
[55] Husseiny MI, Anastasi B, Singer J, Lacey SF. Comparative polyomavirus infections study. J Clin Virol. 2010;49(2):137-40. https://doi.org/10.1016/j.jcv.2010.06.017
[56] Mertz KD, Junt T, Schmid M, Pfaltz M, Kempf W. Inflammatory monocytes reservoir. J Invest Dermatol. 2010;130(4):1146-51. https://doi.org/10.1038/jid.2009.392
[57] Pancaldi C, Corazzari V, Maniero S, Mazzoni E, Comar M, Martini F, et al. DNA sequences in buffy coats. Blood. 2011;117(26):7099-101. https://doi.org/10.1182/blood-2010-09-310557
[58] Erickson KD, Garcea RL, Tsai B. Ganglioside GT1b receptor. J Virol. 2009;83(19):10275-9. https://doi.org/10.1128/JVI.00949-09
[59] Becker M, Kaucher A, Suda M, Best B, Schadmand E, Schäfer R, et al. Infectious entry of Merkel cell polyomavirus. J Virol. 2019;93(15):e00586-19. https://doi.org/10.1128/JVI.02004-18
[60] Neumann F, Borchert S, Schmidt C, Grundhoff A, Fischer N. Replication and gene expression by MCPyV genome. PLoS One. 2011;6(12):e29112. https://doi.org/10.1371/journal.pone.0029112
[61] Feng H, Kwun HJ, Liu X, Gjoerup O, Stolz DB, Chang Y, Moore PS. Cellular and viral factors regulating replication. PLoS One. 2011;6(7):e22468. https://doi.org/10.1371/journal.pone.0022468
[62] Li J, Wang X, Diaz J, Tsang SH, Buck CB, You J. Large T antigen disrupts genomic integrity. J Virol. 2013;87(16):9173-88. https://doi.org/10.1128/JVI.01216-13
[63] Liu W, Yang R, Payne AS, Schowalter RM, Spurgeon ME, Lambert PF, et al. Target cells and mechanisms of infection. Cell Host Microbe. 2016;19(6):775-87. https://doi.org/10.1016/j.chom.2016.04.024
[64] Bellaud G, Gheit T, Tommasino M, Martin L, Grange F. Polyomavirus DNA in eyebrow hairs. J Eur Acad Dermatol Venereol. 2015;29(5):1019-21. https://doi.org/10.1111/jdv.12439
[65] Hampras SS, Rollison DE, Giuliano AR, McKay-Chopin S, Minoni L, Silling S, et al. T-antigen seroreactivity and SCC. Infect Agents Cancer. 2015;10:35. https://doi.org/10.1186/s13027-015-0030-0
[66] Peretti A, FitzGerald PC, Bliskovsky V, Pastrana DV, Buck CB. Betapapillomavirus and MCPyV in CLL patients. Br J Dermatol. 2014;171(6):1525-8. https://doi.org/10.1111/bjd.13215
[67] Saláková M, Kosťová M, Fraiberk M, Šmahel M, Kodeš Z, Hamsikova E, et al. Detection of MCPyV, HPyV6, HPyV7. J Med Virol. 2016;88(4):695-702. https://doi.org/10.1002/jmv.24385
[68] Diaz J, Wang X, Tsang SH, Jiao J, You J. Phosphorylation of large T antigen. Cancers. 2014;6(3):1532-48. https://doi.org/10.3390/cancers6031464
[69] Krump NA, Wang R, Liu W, Yang JF, Ma T, You J. Antiviral innate immune response. J Virol. 2021;95(8):e02211-20. https://doi.org/10.1128/JVI.02211-20
[70] Shahzad N, Shuda M, Gheit T, Kwun HJ, Cornet I, Saidj D, et al. Downregulates Toll-like receptor 9 expression. J Virol. 2013;87(23):13009-19. https://doi.org/10.1128/JVI.01786-13
[71] Liu W, You J. Infection of animal dermal fibroblasts. J Virol. 2018;92(15):e00570-18. https://doi.org/10.1128/JVI.01610-17
[72] Hanly AJ, Elgart GW, Jorda M, Smith J, Nadji M. TTF-1 and CK20 analysis. J Cutan Pathol. 2000;27(3):118-20. https://doi.org/10.1034/j.1600-0560.2000.027003118.x
[73] Moll I, Moll R. Cytokeratin 20 marker. J Invest Dermatol. 1995;104(6):910-5. https://doi.org/10.1111/1523-1747.ep12606183
[74] Shuda M, Guastafierro A, Geng X, Shuda Y, Ostertag EM, Feng H, et al. Small T antigen induces cancer in mouse model. PLoS One. 2015;10(11):e0142329. https://doi.org/10.1371/journal.pone.0142329
[75] Moll I, Zieger W, Schmelz M. Proliferative Merkel cells not detected. Arch Dermatol Res. 1996;288(3):184. https://doi.org/10.1007/BF02505222
[76] Iacocca MV, Abernethy JL, Stefanato CM, Allan AE, Bhawan J. Mixed Merkel and squamous carcinoma. J Am Acad Dermatol. 1998;39(5 Pt 2):882-7. https://doi.org/10.1016/S0190-9622(98)70372-X
[77] Kervarrec T, Samimi M, Gaborit P, Frouin E, Beby-Defaux A, Lorette G, et al. Polyomavirus-positive carcinoma from trichoblastoma. J Invest Dermatol. 2020;140(5):976-85. https://doi.org/10.1016/j.jid.2019.09.026
[78] zur Hausen A, Rennspiess D, Winnepenninckx V, Speel EJ, Kather H, Schrama D, Becker JC. Early B-cell differentiation. Cancer Res. 2013;73(16):4982. https://doi.org/10.1158/0008-5472.CAN-13-0616
[79] Sunshine JC, Jahchan NS, Sage J, Choi J. Multiple cells of origin. Oncogene. 2018;37(11):1409-16. https://doi.org/10.1038/s41388-017-0073-3
[80] Yang JF, You J. Merkel cell polyomavirus and associated carcinoma. Tumour Virus Res. 2022;13:200232. https://doi.org/10.1016/j.tvr.2021.200232
[81] Sadeghi M, Aronen P, Chen T, Eklund C, Kainulainen H, Hedman K. MCPyV DNAs and antibodies in elderly. BMC Infect Dis. 2012;12:383. https://doi.org/10.1186/1471-2334-12-383
[82] Koljonen V, Kukko H, Pukkala E, Sankila R, Böhling T, Tukiainen E, et al. CLL patients risk of MCPyV-positive carcinoma. Br J Cancer. 2009;101(8):1444-7. https://doi.org/10.1038/sj.bjc.6605306
[83] Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167-97. https://doi.org/10.1016/j.ccell.2020.06.001
[84] Toyokuni S. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid Redox Signal. 2006;8(7-8):1373-7. https://doi.org/10.1089/ars.2006.8.1373
[85] Parisi I, Martin Collinson J. Regulation of Merkel cell development by Pax6. Int J Dev Biol. 2012;56(5):341-50. https://doi.org/10.1387/ijdb.113406ip
[86] Chung J, Huda MN, Shin Y, Han S, Akter S, Kang I, et al. Correlation between Oxidative Stress and Transforming Growth Factor-Beta in Cancers. Int J Mol Sci. 2021;22(24):13181. https://doi.org/10.3390/ijms222413181
[87] Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137(6):1062-75. https://doi.org/10.1016/j.cell.2009.03.048
[88] Lin Z, McDermott A, Shao L, Kannan A, Morgan M, Stack BC Jr, et al. Chronic mTOR activation promotes cell survival in Merkel cell carcinoma. Cancer Lett. 2014;344(2):272-81. https://doi.org/10.1016/j.canlet.2013.11.005
[89] McAdam E, Brem R, Karran P. Oxidative stress-induced protein damage inhibits DNA repair and determines mutation risk and therapeutic efficacy. Mol Cancer Res. 2016;14(7):612-22. https://doi.org/10.1158/1541-7786.MCR-16-0053
[90] Markou T, Dowling AA, Kelly T, Lazou A. Regulation of Bcl-2 phosphorylation in response to oxidative stress in cardiac myocytes. Free Radic Res. 2009;43(9):809-16. https://doi.org/10.1080/10715760903071649
[91] Kumar A, Pant MC, Singh HS, Khandelwal S. Assessment of the Redox Profile and Oxidative DNA Damage (8-OHdG) in Squamous Cell Carcinoma of Head and Neck. Asian Pac J Cancer Prev. 2012;13(6):2603-7.
[92] Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2'-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27(2):120-39. https://doi.org/10.1080/10590500902885684
[93] Su CJ, Lan J, Lee CH. A 10-case series of Merkel cell carcinoma in tropical Taiwan: Focusing on clinical outcomes and the interaction of oxidative stress and Merkel cell polyomavirus infections. Dermatol Sin. 2022;40(1):28-34. https://doi.org/10.4103/ds.ds_12_22
[94] Cui J, Pan Y, Wang J, Liu Y, Wang X. MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD. Oncol Lett. 2018;16(5):5946-52. https://doi.org/10.3892/ol.2018.9326
[95] Nogueira V, Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res. 2013;19(16):4309-14. https://doi.org/10.1158/1078-0432.CCR-12-1424
[96] Knepper TC, Montesion M, Russell JS, Sokol ES, Frampton GM, Miller VA, et al. The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy. Clin Cancer Res. 2019;25(20):5961-71. https://doi.org/10.1158/1078-0432.CCR-18-4159
[97] Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol. 2011;6(1):45-57. https://doi.org/10.2217/fvl.10.73
[98] Castle PE, Giuliano AR. Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr. 2003;(31):29-34. https://doi.org/10.1093/oxfordjournals.jncimonographs.a003478
[99] Zhang R, Zhang N, Zhang H, Liu C, Dong X, Li X, et al. Celastrol prevents cadmium-induced neuronal cell death by blocking mitochondrial ROS inactivation of AMPK and activation of mTOR pathway. Br J Pharmacol. 2016;173(18):2746-61.
[100] Tiwari M, Chaube SK. Moderate increase of reactive oxygen species triggers meiotic resumption in rat follicular oocytes. J Obstet Gynaecol Res. 2016;42(5):536-46. https://doi.org/10.1111/jog.12938
[101] Giergiel M, Lopucki M, Stachowicz N, Kankofer M. The influence of age and gender on antioxidant enzyme activities in humans and laboratory animals. Aging Clin Exp Res. 2012;24(6):561-9. https://doi.org/10.1007/BF03654838
[102] Xing X, Dan Y, Xu Z, Xiang L. Implications of Oxidative Stress in the Pathogenesis and Treatment of Hyperpigmentation Disorders. Oxid Med Cell Longev. 2022;2022:9874321. https://doi.org/10.1155/2022/7881717
[103] Agnelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832-41. https://doi.org/10.1016/S0190-9622(03)02108-X
[104] Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077. https://doi.org/10.1038/nrdp.2017.77
[105] Dandri M, Burda MR, Bürkle A, Zuckerman DM, Will H, Rogler CE. Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology. 2002;35(1):217-23. https://doi.org/10.1053/jhep.2002.30203
[106] Williams VM, Filippova M, Filippov V, Payne KJ, Duerksen-Hughes P. Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol. 2014;88(12):6751-61. https://doi.org/10.1128/JVI.03355-13
[107] Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: pooled analysis of the IARC study. Cancer Causes Control. 2003;14(9):805-14. https://doi.org/10.1023/B:CACO.0000003811.98261.3e
[108] Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J. Sexual behavior and smoking as determinants of cervical HPV infection and CIN3. Br J Cancer. 2000;83(11):1565-72. https://doi.org/10.1054/bjoc.2000.1523
[109] Finan RR, Musharrafieh U, Almawi WY. Detection of Chlamydia trachomatis and HSV in cervical samples. Clin Microbiol Infect. 2006;12(9):927-30. https://doi.org/10.1111/j.1469-0691.2006.01479.x
[110] Hawes SE, Kiviat NB. Are genital infections and inflammation cofactors in invasive cervical cancer? J Natl Cancer Inst. 2002;94(21):1592-3. https://doi.org/10.1093/jnci/94.21.1592
[111] Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, et al. Association of cervical inflammation with high-grade cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2001;10(10):1021-7.
[112] Petersen J, Dandri M, Bürkle A, Zhang L, Rogler CE. Increase in hepadnavirus DNA integrations by oxidative DNA damage. J Virol. 1997;71(7):5455-63. https://doi.org/10.1128/jvi.71.7.5455-5463.1997
[113] Letafati A, Taghiabadi Z, Zafarian N, Nikzad A, Shafiei Javan S, Najafi S, et al. Emerging paradigms: oxidative stress in HPV-induced carcinogenesis. Infect Agents Cancer. 2024;19(1):30. https://doi.org/10.1186/s13027-024-00581-8
[114] Letafati A, Soheili R, Norouzi M, Soleimani P, Mozhgani SH. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma. Med Oncol. 2023;40(10):295. https://doi.org/10.1007/s12032-023-02166-8
[115] Letafati A, Motlaghzadeh S, Ardekani OS, Askari FS, Zafarian N, Shafiei Javan S, et al. High distribution of HPV genotypes in Karaj, Iran. Virol J. 2024;21(1):182. https://doi.org/10.1186/s12985-024-02457-0
[1] Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778-89. https://doi.org/10.1002/ijc.33588
[2] Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108. https://doi.org/10.3322/canjclin.55.2.74
[3] zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392(1):1-10. https://doi.org/10.1016/j.virol.2009.06.001
[4] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2011;100B:1-636.
[5] Zuckerman AJ. IARC monographs on the evaluation of carcinogenic risks to humans. J Clin Pathol. 1995;48(7):691. https://doi.org/10.1136/jcp.48.7.691-a
[6] Qian W, Wiman KG. Polyoma virus middle T and small t antigens cooperate to antagonize p53-induced cell cycle arrest and apoptosis. Cell Growth Differ. 2000;11(1):31-9.
[7] Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107-10. https://doi.org/10.1001/archderm.1972.01620040075020
[8] Urso C. A tumour, a cell, a misunderstanding: trabecular (Merkel cell) carcinoma of the skin. J Clin Pathol. 1991;44(9):781. https://doi.org/10.1136/jcp.44.9.781
[9] Spurgeon ME, Lambert PF. Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology. 2013;435(1):118-30. https://doi.org/10.1016/j.virol.2012.09.029
[10] Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077. https://doi.org/10.1038/nrdp.2017.77
[11] Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 5th ed. Oxford: Oxford University Press; 2015. https://doi.org/10.1093/acprof:oso/9780198717478.001.0001
[12] Wongworawat YC, Filippova M, Williams VM, Filippov V, Duerksen-Hughes PJ. Chronic oxidative stress increases the integration frequency of foreign DNA and human papillomavirus 16 in human keratinocytes. Am J Cancer Res. 2016;6(4):764-80.
[13] Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994;344(8924):721-4. https://doi.org/10.1016/S0140-6736(94)92211-X
[14] Battisti V, Maders LD, Bagatini MD, Reetz LG, Chiesa J, Battisti IE, et al. Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis. Biomed Pharmacother. 2011;65(7):516-24. https://doi.org/10.1016/j.biopha.2011.06.003
[15] Liu W, Krump NA, Buck CB, You J. Merkel cell polyomavirus infection and detection. J Vis Exp. 2019;(144):e58950. https://doi.org/10.3791/58950
[16] Liu W, Yang R, Payne AS, Schowalter RM, Spurgeon ME, Lambert PF, et al. Identifying the target cells and mechanisms of Merkel cell polyomavirus infection. Cell Host Microbe. 2016;19(6):775-87. https://doi.org/10.1016/j.chom.2016.04.024
[17] Chang Y, Moore PS. Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol. 2012;7:123-44. https://doi.org/10.1146/annurev-pathol-011110-130227
[18] Calzavara-Pinton P, Monari P, Manganoni AM, Ungari M, Rossi M, Gualdi G, et al. Merkel cell carcinoma arising in immunosuppressed patients treated with high-dose ultraviolet A1 (320-400 nm) phototherapy: a report of two cases. Photodermatol Photoimmunol Photomed. 2010;26(5):263-5. https://doi.org/10.1111/j.1600-0781.2010.00529.x
[19] Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077. https://doi.org/10.1038/nrdp.2017.77
[20] Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107-10. https://doi.org/10.1001/archderm.1972.01620040075020
[21] Colunga A, Pulliam T, Nghiem P. Merkel cell carcinoma in the age of immunotherapy: facts and hopes. Clin Cancer Res. 2017;24(9):2035-43. https://doi.org/10.1158/1078-0432.CCR-17-0439
[22] Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096-100. https://doi.org/10.1126/science.1152586
[23] Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009;5(9):e1000578. https://doi.org/10.1371/journal.ppat.1000578
[24] Schowalter RM, Pastrana DV, Buck CB. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog. 2011;7(7):e1002161. https://doi.org/10.1371/journal.ppat.1002161
[25] Schowalter RM, Reinhold WC, Buck CB. Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One. 2012;7(7):e42181. https://doi.org/10.1371/journal.pone.0042181
[26] Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe. 2010;7(6):509-15. https://doi.org/10.1016/j.chom.2010.05.006
[27] Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, et al. Human Merkel cell polyomavirus infection II. Int J Cancer. 2009;125(6):1250-6. https://doi.org/10.1002/ijc.24509
[28] Czech-Sioli M, Günther T, Therre M, Spohn M, Indenbirken D, Theiss J, et al. High-resolution analysis of Merkel cell polyomavirus. PLoS Pathog. 2020;16(6):e1008562. https://doi.org/10.1371/journal.ppat.1008562
[29] Martel-Jantin C, Filippone C, Cassar O, Peter M, Tomasic G, Vielh P, et al. Genetic variability and integration of Merkel cell polyomavirus. Virology. 2012;426(2):134-42. https://doi.org/10.1016/j.virol.2012.01.018
[30] Starrett GJ, Thakuria M, Chen T, Marcelus C, Cheng J, Nomburg J, et al. Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med. 2020;12(1):30. https://doi.org/10.1186/s13073-020-00727-4
[31] Borchert S, Czech-Sioli M, Neumann F, Schmidt C, Wimmer P, Dobner T, et al. High-affinity Rb binding and transformation by Merkel cell polyomavirus large T antigens. J Virol. 2014;88(6):3144-60. https://doi.org/10.1128/JVI.02916-13
[32] Houben R, Adam C, Baeurle A, Hesbacher S, Grimm J, Angermeyer S, et al. Retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen. Int J Cancer. 2012;130(4):847-56. https://doi.org/10.1002/ijc.26076
[33] Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, et al. Pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol. 2009;218(1):48-56. https://doi.org/10.1002/path.2532
[34] Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. T antigen mutations are a human tumor-specific signature. Proc Natl Acad Sci USA. 2008;105(42):16272-7. https://doi.org/10.1073/pnas.0806526105
[35] Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, et al. Viral T antigens required for Merkel cell carcinoma cells. J Virol. 2010;84(14):7064-72. https://doi.org/10.1128/JVI.02400-09
[36] Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. Small T antigen targeting 4E-BP1. J Clin Invest. 2011;121(9):3623-34. https://doi.org/10.1172/JCI46323
[37] Verhaegen ME, Mangelberger D, Harms PW, Vozheiko TD, Weick JW, Wilbert DM, et al. Small T antigen is oncogenic in transgenic mice. J Invest Dermatol. 2015;135(5):1415-24. https://doi.org/10.1038/jid.2014.446
[38] Grundhoff A, Fischer N. Merkel cell polyomavirus. Curr Opin Virol. 2015;14:129-37. https://doi.org/10.1016/j.coviro.2015.08.010
[39] Liu W, Krump NA, You J. Merkel cell polyomavirus infection and carcinoma. Curr Opin Virol. 2016;20:20-7. https://doi.org/10.1016/j.coviro.2016.07.011
[40] Liu W, You J. Molecular mechanisms of transformation and replication. Annu Rev Virol. 2020;7:289-307. https://doi.org/10.1146/annurev-virology-011720-121757
[41] Spurgeon ME, Lambert PF. Merkel cell polyomavirus. Virology. 2013;435(1):118-30. https://doi.org/10.1016/j.virol.2012.09.029
[42] Wendzicki JA, Moore PS, Chang Y. Large T and small T antigens. Curr Opin Virol. 2015;11:38-43. https://doi.org/10.1016/j.coviro.2015.01.009
[43] Terheyden P, Becker JC. New developments in metastatic Merkel cell carcinoma. Curr Opin Oncol. 2017;29(3):221-6. https://doi.org/10.1097/CCO.0000000000000363
[44] Tang CK, Toker C. Trabecular carcinoma: ultrastructural study. Cancer. 1978;42(5):2311-21. https://doi.org/10.1002/1097-0142(197811)42:5<2311::AID-CNCR2820420531>3.0.CO;2-L
[45] Chen T, Hudnall SD, Buck CB, Feng H, Moore PS, Chang Y. Serological evidence of primary infections in childhood. J Clin Virol. 2011;50(2):125-9. https://doi.org/10.1016/j.jcv.2010.10.015
[46] Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009;5(3):e1000363. https://doi.org/10.1371/journal.ppat.1000363
[47] Tolstov YL, Knauer A, Chen JG, Kensler TW, Chang Y, Moore PS. Asymptomatic primary infection among adults. Emerg Infect Dis. 2011;17(8):1371-80. https://doi.org/10.3201/eid1708.110079
[48] Touzé A, Le Bidre E, Laude H, Fleury MJ, Cazal R, Arnoult D, et al. Antibodies and clinical outcome. J Clin Oncol. 2011;29(12):1612-9. https://doi.org/10.1200/JCO.2010.31.1704
[49] Pastrana DV, Wieland U, Silling S, Buck CB, Pfister H. Viral load and antibody titer correlation. Med Microbiol Immunol. 2012;201(1):17-23. https://doi.org/10.1007/s00430-011-0200-7
[50] Viscidi RP, Rollison DE, Sondak VK, Silver B, Messina JL, Giuliano AR, et al. Age-specific seroprevalence. Clin Vaccine Immunol. 2011;18(10):1737-43. https://doi.org/10.1128/CVI.05175-11
[51] Wieland U, Mauch C, Kreuter A, Krieg T, Pfister H. Merkel cell polyomavirus DNA in persons without carcinoma. Emerg Infect Dis. 2009;15(9):1496-8. https://doi.org/10.3201/eid1509.081575
[52] Abedi Kiasari B, Vallely PJ, Klapper PE. Merkel cell polyomavirus DNA in respiratory disease. J Med Virol. 2011;83(12):2220-4. https://doi.org/10.1002/jmv.22222
[53] Bialasiewicz S, Lambert SB, Whiley DM, Nissen MD, Sloots TP. Merkel cell polyomavirus DNA in respiratory specimens. Emerg Infect Dis. 2009;15(3):492-4. https://doi.org/10.3201/eid1503.081067
[54] Goh S, Lindau C, Tiveljung-Lindell A, Allander T. Merkel cell polyomavirus in respiratory secretions. Emerg Infect Dis. 2009;15(3):489-91. https://doi.org/10.3201/eid1503.081206
[55] Husseiny MI, Anastasi B, Singer J, Lacey SF. Comparative polyomavirus infections study. J Clin Virol. 2010;49(2):137-40. https://doi.org/10.1016/j.jcv.2010.06.017
[56] Mertz KD, Junt T, Schmid M, Pfaltz M, Kempf W. Inflammatory monocytes reservoir. J Invest Dermatol. 2010;130(4):1146-51. https://doi.org/10.1038/jid.2009.392
[57] Pancaldi C, Corazzari V, Maniero S, Mazzoni E, Comar M, Martini F, et al. DNA sequences in buffy coats. Blood. 2011;117(26):7099-101. https://doi.org/10.1182/blood-2010-09-310557
[58] Erickson KD, Garcea RL, Tsai B. Ganglioside GT1b receptor. J Virol. 2009;83(19):10275-9. https://doi.org/10.1128/JVI.00949-09
[59] Becker M, Kaucher A, Suda M, Best B, Schadmand E, Schäfer R, et al. Infectious entry of Merkel cell polyomavirus. J Virol. 2019;93(15):e00586-19. https://doi.org/10.1128/JVI.02004-18
[60] Neumann F, Borchert S, Schmidt C, Grundhoff A, Fischer N. Replication and gene expression by MCPyV genome. PLoS One. 2011;6(12):e29112. https://doi.org/10.1371/journal.pone.0029112
[61] Feng H, Kwun HJ, Liu X, Gjoerup O, Stolz DB, Chang Y, Moore PS. Cellular and viral factors regulating replication. PLoS One. 2011;6(7):e22468. https://doi.org/10.1371/journal.pone.0022468
[62] Li J, Wang X, Diaz J, Tsang SH, Buck CB, You J. Large T antigen disrupts genomic integrity. J Virol. 2013;87(16):9173-88. https://doi.org/10.1128/JVI.01216-13
[63] Liu W, Yang R, Payne AS, Schowalter RM, Spurgeon ME, Lambert PF, et al. Target cells and mechanisms of infection. Cell Host Microbe. 2016;19(6):775-87. https://doi.org/10.1016/j.chom.2016.04.024
[64] Bellaud G, Gheit T, Tommasino M, Martin L, Grange F. Polyomavirus DNA in eyebrow hairs. J Eur Acad Dermatol Venereol. 2015;29(5):1019-21. https://doi.org/10.1111/jdv.12439
[65] Hampras SS, Rollison DE, Giuliano AR, McKay-Chopin S, Minoni L, Silling S, et al. T-antigen seroreactivity and SCC. Infect Agents Cancer. 2015;10:35. https://doi.org/10.1186/s13027-015-0030-0
[66] Peretti A, FitzGerald PC, Bliskovsky V, Pastrana DV, Buck CB. Betapapillomavirus and MCPyV in CLL patients. Br J Dermatol. 2014;171(6):1525-8. https://doi.org/10.1111/bjd.13215
[67] Saláková M, Kosťová M, Fraiberk M, Šmahel M, Kodeš Z, Hamsikova E, et al. Detection of MCPyV, HPyV6, HPyV7. J Med Virol. 2016;88(4):695-702. https://doi.org/10.1002/jmv.24385
[68] Diaz J, Wang X, Tsang SH, Jiao J, You J. Phosphorylation of large T antigen. Cancers. 2014;6(3):1532-48. https://doi.org/10.3390/cancers6031464
[69] Krump NA, Wang R, Liu W, Yang JF, Ma T, You J. Antiviral innate immune response. J Virol. 2021;95(8):e02211-20. https://doi.org/10.1128/JVI.02211-20
[70] Shahzad N, Shuda M, Gheit T, Kwun HJ, Cornet I, Saidj D, et al. Downregulates Toll-like receptor 9 expression. J Virol. 2013;87(23):13009-19. https://doi.org/10.1128/JVI.01786-13
[71] Liu W, You J. Infection of animal dermal fibroblasts. J Virol. 2018;92(15):e00570-18. https://doi.org/10.1128/JVI.01610-17
[72] Hanly AJ, Elgart GW, Jorda M, Smith J, Nadji M. TTF-1 and CK20 analysis. J Cutan Pathol. 2000;27(3):118-20. https://doi.org/10.1034/j.1600-0560.2000.027003118.x
[73] Moll I, Moll R. Cytokeratin 20 marker. J Invest Dermatol. 1995;104(6):910-5. https://doi.org/10.1111/1523-1747.ep12606183
[74] Shuda M, Guastafierro A, Geng X, Shuda Y, Ostertag EM, Feng H, et al. Small T antigen induces cancer in mouse model. PLoS One. 2015;10(11):e0142329. https://doi.org/10.1371/journal.pone.0142329
[75] Moll I, Zieger W, Schmelz M. Proliferative Merkel cells not detected. Arch Dermatol Res. 1996;288(3):184. https://doi.org/10.1007/BF02505222
[76] Iacocca MV, Abernethy JL, Stefanato CM, Allan AE, Bhawan J. Mixed Merkel and squamous carcinoma. J Am Acad Dermatol. 1998;39(5 Pt 2):882-7. https://doi.org/10.1016/S0190-9622(98)70372-X
[77] Kervarrec T, Samimi M, Gaborit P, Frouin E, Beby-Defaux A, Lorette G, et al. Polyomavirus-positive carcinoma from trichoblastoma. J Invest Dermatol. 2020;140(5):976-85. https://doi.org/10.1016/j.jid.2019.09.026
[78] zur Hausen A, Rennspiess D, Winnepenninckx V, Speel EJ, Kather H, Schrama D, Becker JC. Early B-cell differentiation. Cancer Res. 2013;73(16):4982. https://doi.org/10.1158/0008-5472.CAN-13-0616
[79] Sunshine JC, Jahchan NS, Sage J, Choi J. Multiple cells of origin. Oncogene. 2018;37(11):1409-16. https://doi.org/10.1038/s41388-017-0073-3
[80] Yang JF, You J. Merkel cell polyomavirus and associated carcinoma. Tumour Virus Res. 2022;13:200232. https://doi.org/10.1016/j.tvr.2021.200232
[81] Sadeghi M, Aronen P, Chen T, Eklund C, Kainulainen H, Hedman K. MCPyV DNAs and antibodies in elderly. BMC Infect Dis. 2012;12:383. https://doi.org/10.1186/1471-2334-12-383
[82] Koljonen V, Kukko H, Pukkala E, Sankila R, Böhling T, Tukiainen E, et al. CLL patients risk of MCPyV-positive carcinoma. Br J Cancer. 2009;101(8):1444-7. https://doi.org/10.1038/sj.bjc.6605306
[83] Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38(2):167-97. https://doi.org/10.1016/j.ccell.2020.06.001
[84] Toyokuni S. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid Redox Signal. 2006;8(7-8):1373-7. https://doi.org/10.1089/ars.2006.8.1373
[85] Parisi I, Martin Collinson J. Regulation of Merkel cell development by Pax6. Int J Dev Biol. 2012;56(5):341-50. https://doi.org/10.1387/ijdb.113406ip
[86] Chung J, Huda MN, Shin Y, Han S, Akter S, Kang I, et al. Correlation between Oxidative Stress and Transforming Growth Factor-Beta in Cancers. Int J Mol Sci. 2021;22(24):13181. https://doi.org/10.3390/ijms222413181
[87] Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137(6):1062-75. https://doi.org/10.1016/j.cell.2009.03.048
[88] Lin Z, McDermott A, Shao L, Kannan A, Morgan M, Stack BC Jr, et al. Chronic mTOR activation promotes cell survival in Merkel cell carcinoma. Cancer Lett. 2014;344(2):272-81. https://doi.org/10.1016/j.canlet.2013.11.005
[89] McAdam E, Brem R, Karran P. Oxidative stress-induced protein damage inhibits DNA repair and determines mutation risk and therapeutic efficacy. Mol Cancer Res. 2016;14(7):612-22. https://doi.org/10.1158/1541-7786.MCR-16-0053
[90] Markou T, Dowling AA, Kelly T, Lazou A. Regulation of Bcl-2 phosphorylation in response to oxidative stress in cardiac myocytes. Free Radic Res. 2009;43(9):809-16. https://doi.org/10.1080/10715760903071649
[91] Kumar A, Pant MC, Singh HS, Khandelwal S. Assessment of the Redox Profile and Oxidative DNA Damage (8-OHdG) in Squamous Cell Carcinoma of Head and Neck. Asian Pac J Cancer Prev. 2012;13(6):2603-7.
[92] Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2'-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27(2):120-39. https://doi.org/10.1080/10590500902885684
[93] Su CJ, Lan J, Lee CH. A 10-case series of Merkel cell carcinoma in tropical Taiwan: Focusing on clinical outcomes and the interaction of oxidative stress and Merkel cell polyomavirus infections. Dermatol Sin. 2022;40(1):28-34. https://doi.org/10.4103/ds.ds_12_22
[94] Cui J, Pan Y, Wang J, Liu Y, Wang X. MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD. Oncol Lett. 2018;16(5):5946-52. https://doi.org/10.3892/ol.2018.9326
[95] Nogueira V, Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res. 2013;19(16):4309-14. https://doi.org/10.1158/1078-0432.CCR-12-1424
[96] Knepper TC, Montesion M, Russell JS, Sokol ES, Frampton GM, Miller VA, et al. The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy. Clin Cancer Res. 2019;25(20):5961-71. https://doi.org/10.1158/1078-0432.CCR-18-4159
[97] Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol. 2011;6(1):45-57. https://doi.org/10.2217/fvl.10.73
[98] Castle PE, Giuliano AR. Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr. 2003;(31):29-34. https://doi.org/10.1093/oxfordjournals.jncimonographs.a003478
[99] Zhang R, Zhang N, Zhang H, Liu C, Dong X, Li X, et al. Celastrol prevents cadmium-induced neuronal cell death by blocking mitochondrial ROS inactivation of AMPK and activation of mTOR pathway. Br J Pharmacol. 2016;173(18):2746-61.
[100] Tiwari M, Chaube SK. Moderate increase of reactive oxygen species triggers meiotic resumption in rat follicular oocytes. J Obstet Gynaecol Res. 2016;42(5):536-46. https://doi.org/10.1111/jog.12938
[101] Giergiel M, Lopucki M, Stachowicz N, Kankofer M. The influence of age and gender on antioxidant enzyme activities in humans and laboratory animals. Aging Clin Exp Res. 2012;24(6):561-9. https://doi.org/10.1007/BF03654838
[102] Xing X, Dan Y, Xu Z, Xiang L. Implications of Oxidative Stress in the Pathogenesis and Treatment of Hyperpigmentation Disorders. Oxid Med Cell Longev. 2022;2022:9874321. https://doi.org/10.1155/2022/7881717
[103] Agnelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832-41. https://doi.org/10.1016/S0190-9622(03)02108-X
[104] Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077. https://doi.org/10.1038/nrdp.2017.77
[105] Dandri M, Burda MR, Bürkle A, Zuckerman DM, Will H, Rogler CE. Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology. 2002;35(1):217-23. https://doi.org/10.1053/jhep.2002.30203
[106] Williams VM, Filippova M, Filippov V, Payne KJ, Duerksen-Hughes P. Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol. 2014;88(12):6751-61. https://doi.org/10.1128/JVI.03355-13
[107] Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: pooled analysis of the IARC study. Cancer Causes Control. 2003;14(9):805-14. https://doi.org/10.1023/B:CACO.0000003811.98261.3e
[108] Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J. Sexual behavior and smoking as determinants of cervical HPV infection and CIN3. Br J Cancer. 2000;83(11):1565-72. https://doi.org/10.1054/bjoc.2000.1523
[109] Finan RR, Musharrafieh U, Almawi WY. Detection of Chlamydia trachomatis and HSV in cervical samples. Clin Microbiol Infect. 2006;12(9):927-30. https://doi.org/10.1111/j.1469-0691.2006.01479.x
[110] Hawes SE, Kiviat NB. Are genital infections and inflammation cofactors in invasive cervical cancer? J Natl Cancer Inst. 2002;94(21):1592-3. https://doi.org/10.1093/jnci/94.21.1592
[111] Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, et al. Association of cervical inflammation with high-grade cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2001;10(10):1021-7.
[112] Petersen J, Dandri M, Bürkle A, Zhang L, Rogler CE. Increase in hepadnavirus DNA integrations by oxidative DNA damage. J Virol. 1997;71(7):5455-63. https://doi.org/10.1128/jvi.71.7.5455-5463.1997
[113] Letafati A, Taghiabadi Z, Zafarian N, Nikzad A, Shafiei Javan S, Najafi S, et al. Emerging paradigms: oxidative stress in HPV-induced carcinogenesis. Infect Agents Cancer. 2024;19(1):30. https://doi.org/10.1186/s13027-024-00581-8
[114] Letafati A, Soheili R, Norouzi M, Soleimani P, Mozhgani SH. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma. Med Oncol. 2023;40(10):295. https://doi.org/10.1007/s12032-023-02166-8
[115] Letafati A, Motlaghzadeh S, Ardekani OS, Askari FS, Zafarian N, Shafiei Javan S, et al. High distribution of HPV genotypes in Karaj, Iran. Virol J. 2024;21(1):182. https://doi.org/10.1186/s12985-024-02457-0
| Files | ||
| Issue | Vol 1 No 1 (2026) | |
| Section | Review Article(s) | |
| Keywords | ||
| MCV Pax6 p62 G6PD Oxidative stress Merkel cell | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
lotfi H, Esfandiari A, Zarezadeh M, Talebi Z, Etrati Kooshali A, Sheydaei N, Naderisemiromi M. MCPyV and Oxidative Stress: Focus on Mechanism of Action Associated with Merkel Cell Carcinoma. ipj. 2026;1(1):45-55.
